ReNeuron Group plc Stock
Your prediction
Pros and Cons of ReNeuron Group plc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ReNeuron Group plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ReNeuron Group plc | - | - | - | - | - | - | - |
| Proteome Sciences | - | 0.000% | 0.000% | 25.000% | 6.667% | -32.773% | 300.000% |
| Oxford BioMedica PLC | 12.200% | 30.159% | 50.459% | -33.061% | 34.426% | -73.548% | -57.403% |
| Sareum Holdings plc | -4.170% | -3.356% | 116.541% | -78.978% | -53.171% | -76.960% | - |
Comments
News
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™
